GAMRIC 2026 panel: phage therapy as a narrow-spectrum antimicrobial strategy

At GAMRIC 2026, JAFRAL CEO Frenk Smrekar joined John Rex, Radu Botgros and Gauri Rao for a panel on phage therapy as a narrow-spectrum antimicrobial strategy, from product concept to late-stage clinical development.